kidney cancer
Macrophage Subpopulation May Predict Kidney Cancer Recurrence, Serve as Drug Target
The macrophage population, which expressed higher levels of three genes, was enriched in tumors of patients who experienced recurrence after surgery.
Allarity Therapeutics Seeks FDA Premarket Approval for Prediction Tool as CDx for Dovitinib
The DRP would be used to identify kidney cancer patients likely to benefit from dovitinib, a repurposed TKI for which Allarity plans to file an NDA this year.
Renal Cell Carcinoma Risk Gene Representation Can Vary With Ancestry
While risky variants in the FH gene were more common in renal cell carcinoma patients with African ancestry, European patients more often carried pathogenic CHEK2 gene changes.
Mutations in Mitochondrial DNA Underlie Certain Subtype of Aggressive Renal Cancer
The researchers said this new data could lead to the development of effective therapies for patients with hereditary leiomyomatosis and renal cell carcinoma.
Brain, Kidney Cancer Studies Lay Path for Clinical Application of Epigenetic Liquid Biopsy Method
Premium
Investigators reported that methylation profiling could distinguish brain cancer subtypes and could detect kidney cancer with striking sensitivity in early experiments.